Twist Bioscience Corporation revised earnings guidance for the fiscal year 2024. For the full fiscal year 2024, total revenue is expected to be in the range of $300 million to $304 million compared to previous guidance of $288 million to $293 million, indicating year over year growth of 22% to 24%.